| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 27.55▼ | 27.55▼ | 27.71▼ | 27.19▼ | 29.30▼ |
| MA10 | 27.87▼ | 27.82▼ | 27.72▼ | 28.22▼ | 29.83▼ |
| MA20 | 27.97▼ | 27.49▼ | 27.45▼ | 29.98▼ | 33.01▼ |
| MA50 | 27.44▼ | 27.48▼ | 27.81▼ | 30.79▼ | 31.15▼ |
| MA100 | 27.62▼ | 28.97▼ | 29.78▼ | 33.46▼ | 27.36▼ |
| MA200 | 29.35▼ | 30.30▼ | 30.54▼ | 32.50▼ | 24.10▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.140▼ | -0.033▼ | 0.061▲ | -0.359▼ | -0.846▼ |
| RSI | 37.766▼ | 42.958▼ | 42.006▼ | 34.777▼ | 37.757▼ |
| STOCH | 14.616▼ | 41.506 | 63.640 | 26.699 | 34.141 |
| WILL %R | -100.000▼ | -85.886▼ | -72.222 | -81.443▼ | -87.703▼ |
| CCI | -185.093▼ | -122.759▼ | -55.496 | -81.467 | -168.336▼ |
| MA | $MSB Price Crossed Below MA(7) | Set Alert |
|
Tuesday, April 28, 2026 06:23 PM
FDA has previously agreed on the design of this 300-patient randomized, placebo-controlled confirmatory Phase 3 trial, and the 12-month primary endpoint of pain reduction as an approvable indication.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/04/26 | 28.08 | 28.08 | 26.35 | 26.68 | 35,285 |
| 28/04/26 | 26.43 | 28.55 | 26.43 | 27.93 | 46,358 |
| 27/04/26 | 26.95 | 27.70 | 26.27 | 26.75 | 51,979 |
| 24/04/26 | 28.2693 | 28.2693 | 26.28 | 27.03 | 55,948 |
| 23/04/26 | 28.75 | 28.77 | 25.24 | 27.56 | 94,926 |
| 22/04/26 | 28.09 | 29.275 | 28.09 | 28.64 | 37,497 |
| 21/04/26 | 28.45 | 29.25 | 27.50 | 28.09 | 32,628 |
| 20/04/26 | 30.00 | 30.505 | 27.02 | 28.45 | 71,815 |
| 17/04/26 | 31.00 | 31.9999 | 30.00 | 30.29 | 60,163 |
| 16/04/26 | 31.305 | 32.3499 | 30.61 | 30.81 | 42,705 |
|
|
||||
|
|
||||
|
|